| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.38 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |